Double Medical(SZ:002901) Sou Hu Cai Jing·2025-08-03 10:27Core Viewpoint - The stock of Dabo Medical (002901) has shown a slight increase, with a closing price of 44.68 yuan on August 1, 2025, reflecting a 0.95% rise, while the overall market sentiment indicates mixed fund flows with significant retail investment [1][2]. Fund Flow Summary - On August 1, 2025, the net outflow of main funds was 685.85 thousand yuan, accounting for 3.72% of the total transaction amount, while retail investors saw a net inflow of 1,061.51 thousand yuan, representing 5.76% of the total [1]. - Over the past five days, the stock experienced fluctuations in fund flows, with notable retail buying on August 1, contrasting with previous days where main and speculative funds showed net outflows [1]. Financial Performance Summary - Dabo Medical reported a main revenue of 550 million yuan for Q1 2025, marking a year-on-year increase of 28.8%, and a net profit attributable to shareholders of 103 million yuan, up 67.04% year-on-year [2]. - The company's gross profit margin stands at 69.64%, significantly higher than the industry average of 51.09%, indicating strong operational efficiency [2]. - Key financial metrics include a total market value of 18.498 billion yuan, a net asset value of 3.307 billion yuan, and a price-to-earnings ratio of 44.85, which is lower than the industry average of 61.54 [2]. Industry Comparison Summary - In the medical device industry, Dabo Medical ranks 14th in total market value among 122 companies, with a net profit ranking of 22nd [2]. - The company's return on equity (ROE) is 3.29%, placing it 16th in the industry, which reflects a competitive position in terms of profitability [2].